Amyloidosis is characterized by the deposition of amyloid fibrils, which cause both functional and structural damage to organs. Cardiac involvement with amyloids is a common cause of secondary cardiomyopathy and leads to congestive heart failure. Pericardial amyloidosis usually occurs at the late or terminal stage of the disease after myocardial involvement, but it is extremely rare for pericardial amyloidosis to proceed with myocardial involvement. Here, we report a rare case of a 66-year-old patient with light-chain myeloma, who presented with pericardial effusion but no evidence of cardiomyopathy. (Korean J Med 2013;84:755-758) 
INTRODUCTION
Amyloidosis develops in 10-15% of patients with light-chain myeloma [1] and involves mainly the kidney, heart, skin, gastrointestinal tract, and nervous system due to light-chain organ tropism, other organs may be involved less frequently [2, 3] . Multi-organ involvement is a very poor prognostic sign, particularly if the heart and bowel are affected [4] . Once the disease becomes symptomatic, it rapidly becomes progressive and usually becomes fatal, with median survival duration of 12-18 months. Fewer than 5% of patients survive for 10 years or longer [5] . However, the course of amyloidosis is difficult to document because determining the time of orgin of the disease is seldom possible [1] .
Pericardial involvement is a rare complication of multiple myeloma, occurring in < 1% of patients and usually manifests at a late stage of the disease [6, 7] . A cardiac amyloidosis is not rare; however, deposit of amyloid in the pericardium without the involvement of the myocardium is extremely rare. Here, we report a rare case of pericardial amyloidosis that was associated with light-chain myeloma, without an evidence of myocardial involvement.
CASE REPORT
A 66-year-old female was admitted to our hospital with dyspnea (Fig. 1A) . Congo-red staining was positive and appeared as a bright greenish birefringency under a polarized light microscope (Fig. 1B ). An electron microscopic examination revealed amyloids in collections of 6-10 nm nonbranched, straight, slightly bent, or rigid-looking fibrils (Fig. 1C) .
A skull X-ray showed osteolytic lesions, but no lesions were Echocardiography showed a thickening of the ventricular wall with granular sparkling on the myocardium, which supported a diagnosis of cardiac amyloidosis. Despite progressive congestive heart failure caused by amyloid infiltration of the myocardium, we decided to treat her symptomatically, without chemotherapy, due to her poor general condition.
DISCUSSION
The main constituent of amyloid deposits is the variable region of the light chains, which are deposited as fibrils throughout the body [4, 5] . In amyloidosis associated with light-chain myeloma, the kappa light chain is the predominant form, with a ratio of 2:1 over the lambda light chain, such as observed in this patient.
However, the ratio of the kappa light chain to the lambda chain is 1:2 in primary idiopathic amyloidosis [1, 5] .
In our case, the patient showed a restrictive pattern of heart failure with pericardial effusion at the time of diagnosis, even though her disease eventually progressed to involve the myocardium. The optimal treatment for malignant involvement of the pericardium in cases of myeloma is not yet known; thus, it is often associated with a poor prognosis, as seen in the cases in Table 1 [ [6] [7] [8] . Among these cases, only two cases mentioned that myeloma was also involved in myocardium. Goldberg et al. [8] reported a case in which plasma cells infiltrated the myocardium. However, the case reported by Rosenbaum et al. [6] showed no involvement of plasma cells in the myocardium. Our patient showed a better prognosis and complete remission for 1 year even in the presence of pericardial amyloidosis. About 10 cases of multiple myeloma with pericardial involvement have been reported since 1966. [7] ; pericardial amyloidosis in cases of multiple myeloma has been reported only rarely. There are several reports of light-chain amyloidosis involving rare sites such as the pleura [9] .
Treatment for amyloidosis is directed both toward the affected organs and toward the specific disease. A patient with restrictive cardiomyopathy who exhibits signs of cardiac amyloidosis may be treated with diuretics. However, this treatment may worsen heart function after the administration of calcium channel blockers, digoxin, and β-blockers [4, 10] . If a patient with multiple myeloma is < 65 years old and does not have severe co-morbidities, then a high dosage of intravenous mephalan (200 mg/m 2 ), as induction chemotherapy, and autologous stem cell transplantation is recommended [11] . Several case reports have documented prolonged survival and resolution of heart failure or proteinuria in patients receiving oral MP. The active plasma cell dyscrasia generally disappears after chemotherapy in these cases, despite 2) A 70-year-old male was diagnosed with Ig D myeloma 3 months ago. Large pericardial effusion with plasma cell infiltration was found. He died 6 weeks later despite treatment with a VAD regimen and direct administration of cyclophosphamide into the pericardium.
3) A 38-year-old female received scheduled chemotherapy. However, she died 4 months later despite salvage chemotherapy (VAD). Myeloma infiltration in the pericardium was found at autopsy.
2002
Arat et al. [7] 3 1) A 48-year-old female was treated with MP and VAD regimens for multiple myeloma for 3 years and then underwent an autologous peripheral stem cell transplantation. Cardiac tamponade with plasma cells infiltration was observed in the pericardial fluid 2 moths later, and she died.
2) A 30-year-old male received initial VAD regimen after a diagnosis of plasma cell leukemia. He died suddenly of cardiac tamponade 2 weeks later. Massive pericardial effusion and malignant plasma cells infiltration were observed at autopsy.
3) A 66-year-old female showed pericardial effusion and was diagnosed with multiple myeloma. A thickened pericardium was heavily infiltrated with plasma cells. She died of sepsis during the first VAD regimen.
persistent amyloidosis in affected tissues [4] .
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